Larvol Delta - Safety-and-Efficacy-of-NK520-to-Treat-Pediatric-RelapsedRefractory-Acute-Myeloid-Leukemia

NK520 - Base Therap

http://clinicaltrials.gov/ct2/show/NCT06541405

Aug 7, 2024

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next